Trial Profile
A Study Assessig The Correlation Between The Pharmacological Effect Of Tolvaptan And The Dynamics Of Urinary AQP2 Levels In Cirrhotic Patients With Massive Ascites Unresponsive To Standard Diuretic Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Pharmacodynamics
- 17 Mar 2017 New trial record